These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 660847)

  • 21. Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial.
    Aller R; de Luis DA; Izaola O; La Calle F; del Olmo L; Fernandez L; Arranz T; Hernandez JM
    Diabetes Res Clin Pract; 2004 Jul; 65(1):7-11. PubMed ID: 15163472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein.
    Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Vidgen E; Lapsley KG; Trautwein EA; Josse RG; Leiter LA; Connelly PW
    JAMA; 2003 Jul; 290(4):502-10. PubMed ID: 12876093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
    Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
    Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
    Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
    N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Huth K; Blumenthal J; Schmahl FW
    Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
    [No Abstract]   [Full Text] [Related]  

  • 30. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.
    Glueck CJ; Fallat R; Tsang R
    Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362
    [No Abstract]   [Full Text] [Related]  

  • 31. The interaction of dietary fibers and cholesterol upon the plasma lipids and lipoproteins, sterol balance, and bowel function in human subjects.
    Raymond TL; Connor WE; Lin DS; Warner S; Fry MM; Connor SL
    J Clin Invest; 1977 Dec; 60(6):1429-37. PubMed ID: 915007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein lipid alterations with cholestyramine administration.
    Jones RJ; Dobrilovic L
    J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of hyperlipidemia].
    Itakura H
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1750-5. PubMed ID: 1336024
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of bran and cholestyramine on plasma lipids in monkeys.
    Malinow MR; McLaughlin P; Papworth L; Naito HK; Lewis LA
    Am J Clin Nutr; 1976 Aug; 29(8):905-11. PubMed ID: 821335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperlipemia: practical attitudes].
    Micheli H
    Schweiz Med Wochenschr; 1976 Jul; 106(27):929-36. PubMed ID: 186864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias].
    Kaffarnik H; Mühlfellner G; Mühlfellner O; Schneider J; Hausmann L; Zöfel P; Schubotz R; Fuchs F
    Fortschr Med; 1977 Dec; 95(46):2785-7. PubMed ID: 590905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.
    Angelin B; Einarsson K; Hellström K; Leijd B
    J Lipid Res; 1978 Nov; 19(8):1017-24. PubMed ID: 731123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.